Morpholine

Morpholine

SCHEMBL18434

C1COCCN1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morpholine SCHEMBL28529603 1.00
Morpholine SCHEMBL18577399 1.00
SCHEMBL6049109 1.00 MEN1 (0.92)
Morpholine SCHEMBL922866 1.00
Morpholine SCHEMBL986 1.00
Morpholine SCHEMBL7996463 1.00 MEN1 (0.92)
Morpholine SCHEMBL3233209 1.00 MEN1 (0.92)
SCHEMBL244992 1.00 MEN1 (0.92)
SCHEMBL22491036 1.00 MEN1 (0.92)
Morpholine SCHEMBL27542862 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6617 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410577-B1 None US claimed
WO-2024138486-A1 TETRACYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-07-04 WO claimed
CN-118265699-A Asymmetric biphenyl derivative and preparation method and medical application thereof 西安新通药物研究股份有限公司 2024-06-28 CN claimed
CN-118221579-A PRMT5 inhibitors 北京望实智慧科技有限公司 2024-06-21 CN claimed
EP-4370506-A1 PYRAZINE COMPOUNDS AS INHIBITORS OF FLT3 Biomea Fusion, Inc. (US) 2024-05-22 EP claimed
EP-4370132-A2 MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS Alnylam Pharmaceuticals, Inc. (US) 2024-05-22 EP claimed
EP-3852766-B1 COMBINATION THERAPY FOR TREATING BLOOD CANCER SIGNALCHEM LIFESCIENCES CORP (CA) 2024-05-08 EP claimed
CN-117982672-A Anti-Nectin-4 antibody drug conjugate and application 百奥泰生物制药股份有限公司 2024-05-07 CN claimed
WO-2024088036-A1 ASYMMETRIC BIPHENYL DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 西安新通药物研究股份有限公司 2024-05-02 WO claimed
WO-2024078387-A1 SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS, AND USES 天津谷堆生物医药科技有限公司 2024-04-18 WO claimed
EP-0110298-A1 Acridanone derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-06-13 EP claimed
EP-0003560-B1 IMIDAZOLE DERIVATIVES AND SALTS THEREOF, THEIR SYNTHESIS, AND PHARMACEUTICAL FORMULATIONS THE WELLCOME FOUNDATION LIMITED (GB) 1984-05-02 EP claimed
EP-0107350-A1 Sulfon amides Beecham Wuelfing GmbH &amp; Co KG (DE) 1984-05-02 EP claimed
EP-0098951-A2 Aminobenzamide derivatives and preparation thereof STERLING DRUG INC. (US) 1984-01-25 EP claimed
US-4416895-A ANTICOAGULANTS, ANTISHOCK AGENTS BURROUGHS WELLCOME CO. (US) 1983-11-22 US claimed
EP-0065488-A1 Process for the preparation of 4-thio-azetidinone compounds CIBA-GEIGY AG (CH) 1982-11-24 EP claimed
EP-0006722-A1 Derivatives of (4-(piperazin-1-yl-phenyloxymethyl)-1.3-dioxolan-2-ylmethyl)-1H-imidazoles and -1H-1.2.4-triazoles, their preparation and use as fungicides and bactericides JANSSEN PHARMACEUTICA N.V. (BE) 1980-01-09 EP claimed
EP-0003560-A2 Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations THE WELLCOME FOUNDATION LIMITED (GB) 1979-08-22 EP claimed
US-4160766-A ANTI-AGGRESSIVES AND ANTIDEPRESSANTS SANDOZ LTD. (CH) 1979-07-10 US claimed
US-4130710-A POLYOLEFIN STABILIZERS CIBA-GEIGY CORPORATION (US) 1978-12-19 US claimed